LSAK
Lesaka Technologies, Inc.
LSAK trails on the overall score without a compensating advantage in the available component scores.
MU
Micron Technology, Inc.
MU has the edge over LSAK overall, supported by stronger valuation and stronger modeled upside.
LSAK Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Stable | |
| Stable |
LSAK's revenue and profitability are currently healthy, and its cash flow and balance sheet are stable.
MU Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
MU's revenue, profitability, cash flow and balance sheet are all currently strong.
LSAK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 111x | $3.32 | — |
| Cheap | 125x | $3.75 | +13% |
| Fair | 140x | $4.19 | +26% |
| Expensive | 146x | $4.39 | +32% |
Historical ranges are pointers, not guarantees.
LSAK has the edge over MU in the historical PE scenario, which offers more potential upside but is not a forecast.
MU PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 4.6x | $798 | — |
| Cheap | 10x | $777 | -2.7% |
| Current | 11x | $798 | — |
| Fair | 22x | $1,646 | +106% |
| Expensive | 32x | $2,404 | +201% |
Historical ranges are pointers, not guarantees.
MU's PE is in its cheap range at 11x. If earnings grow as analysts expect, today's price would be 4.6x next year's earnings.
LSAK Forward outlook
There aren't enough analyst estimates for LSAK to show an outlook.
MU Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for MU, with profitability improving.
LSAK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.03 | +$1.15 |
| Q2 2026 | $0.03 | +$1.17 |
| Q1 2026 | -$0.40 | +$0.42 |
| Q4 2025 | -$0.68 | -$0.07 |
| Q3 2025 | -$1.12 | -$0.87 |
| Q2 2025 | -$1.14 | -$0.87 |
| Q3 2022 | -$0.69 | -$0.30 |
| Q2 2022 | -$0.75 | -$0.08 |
LSAK has returned to profit: it earned $0.03 per share over the past year, after losing money the year before.
MU Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $174.95 | +135% |
| Q3 2026 | $74.33 | +879% |
| Q2 2026 | $44.17 | +693% |
| Q1 2026 | $21.18 | +405% |
| Q4 2025 | $10.52 | +201% |
| Q3 2025 | $7.59 | +984% |
| Q2 2025 | $5.57 | +$6.99 |
| Q1 2025 | $4.19 | +$7.64 |
| Q4 2024 | $3.49 | +$9.77 |
MU has the edge over LSAK on earnings, with more consistent year-over-year improvement.
LSAK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $184.6M | +7.7% |
| Q2 2026 | $188.3M | +12% |
| Q1 2026 | $183.1M | +13% |
| Q4 2025 | $178.7M | +1.4% |
| Q3 2025 | $171.4M | +12% |
| Q2 2025 | $168.5M | +15% |
| Q1 2025 | $161.5M | +17% |
| Q4 2024 | $176.2M | +22% |
LSAK's revenue has grown year over year for 19 quarters in a row: $185M last quarter, up 7.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -0.6% | -0.8 points |
| Q2 2026 | 3.4% | +20 points |
| Q1 2026 | 2.2% | +1.9 points |
| Q4 2025 | 1.2% | +0.8 points |
| Q3 2025 | 0.2% | +0.3 points |
| Q2 2025 | -17% | -17 points |
| Q1 2025 | 0.3% | -0.2 points |
| Q4 2024 | 0.4% | -1.1 points |
LSAK's operating margin was −0.6% last quarter, down 0.8 points from the same quarter a year ago.
MU Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $54.2B | +379% |
| Q2 2026 | $41.5B | +346% |
| Q1 2026 | $23.9B | +196% |
| Q4 2025 | $13.6B | +57% |
| Q3 2025 | $11.3B | +46% |
| Q2 2025 | $9.3B | +37% |
| Q1 2025 | $8.1B | +38% |
| Q4 2024 | $8.7B | +84% |
MU has the edge over LSAK on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 81% | +48 points |
| Q2 2026 | 80% | +57 points |
| Q1 2026 | 68% | +46 points |
| Q4 2025 | 45% | +20 points |
| Q3 2025 | 32% | +13 points |
| Q2 2025 | 23% | +13 points |
| Q1 2025 | 22% | +19 points |
| Q4 2024 | 25% | +49 points |
MU has the edge over LSAK on profitability, with a higher operating margin.
LSAK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$15M | -404% |
| Q2 2026 | $7.5M | +$18.1M |
| Q1 2026 | $34.2M | +336% |
| Q4 2025 | -$14.8M | +$646K |
| Q3 2025 | $4.9M | +$13M |
| Q2 2025 | -$10.6M | -1229% |
| Q1 2025 | $7.8M | -52% |
| Q4 2024 | -$15.5M | -$13.9M |
LSAK's free cash flow has turned positive after six years mostly in the red: $12M over the past year.
MU Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $32.9B | +45543% |
| Q2 2026 | $17.6B | +951% |
| Q1 2026 | $5.5B | +$5.6B |
| Q4 2025 | $3B | +7853% |
| Q3 2025 | $72M | -75% |
| Q2 2025 | $1.7B | +322% |
| Q1 2025 | -$113M | +$52M |
| Q4 2024 | $38M | +$433M |
MU has the edge over LSAK on cash flow, with more consistent year-over-year improvement.
LSAK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +198K shares |
| 1 year | +1.7% | +1.3M shares |
| 3 years | +39% | +22.5M shares |
LSAK has 80M diluted shares, up 1.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $186,000 |
| Q2 2026 | $28,000 |
| Q1 2026 | $40,000 |
| Q4 2025 | $271,000 |
| Q2 2025 | $1M |
| Q1 2025 | $27,000 |
| Q4 2024 | $12.6M |
| Q2 2024 | $1.3M |
MU Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -2M shares |
| 1 year | +1.6% | +18M shares |
| 3 years | +4.6% | +50M shares |
| 5 years | +0.2% | +2M shares |
| Available history | +1.2% | +14M shares |
MU has the edge over LSAK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $350M |
| Q4 2025 | $300M |
| Q3 2024 | $300M |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
MU has spent almost nothing on buybacks in the past year.
LSAK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.3x | Moderate |
| Q2 2026 | 2.2x | Moderate |
| Q1 2026 | 4.3x | High |
| Q4 2025 | 7.2x | High |
| Q3 2025 | 10.0x | High |
| Q2 2025 | 18.8x | High |
| Q1 2025 | 4.0x | High |
| Q4 2024 | 3.1x | Elevated |
LSAK's net debt is about 2.3 years of its operating earnings (EBITDA), down from 10 years a year ago.
MU Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.1x | Net Cash |
| Q4 2025 | 0.1x | Very low |
| Q3 2025 | 0.3x | Very low |
| Q2 2025 | 0.3x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
MU has the edge over LSAK on leverage, with a lower net debt burden relative to earnings.
LSAK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 27.8 | Oversold |
| Stochastic | 5.2 | Oversold |
LSAK's weekly RSI is 28 (oversold) and its Stochastic is 5 (oversold).
MU Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.1 | Neutral |
| Stochastic | 26.9 | Neutral |
MU's weekly RSI is 47 (neutral) and its Stochastic is 27 (neutral).
LSAK PE vs Technology Sector
MU PE vs Technology Sector
| Metric | MU | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 28x | 61% below |
| PE % | 18 | 35 | 17 pts below |
MU is trading at 11x earnings, a 61% discount to the Technology sector's median of 28x.
LSAK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.07 | 18% below |
| 20 week MA | $4.40 | 25% below |
| 50 week MA | $4.58 | 28% below |
| 100 week MA | $4.56 | 27% below |
| 200 week MA | $4.39 | 24% below |
LSAK is in a downtrend: it's below all five of its weekly moving averages, and 24% below its 200-week average.
MU Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $914.5 | 13% below |
| 20 week MA | $931.0 | 14% below |
| 50 week MA | $685.9 | 16% above |
| 100 week MA | $405.4 | 97% above |
| 200 week MA | $246.0 | 225% above |
MU has the edge over LSAK on trend strength, trading above more of its moving averages.
LSAK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $3.74 | $4.74 | +27% |
| 2021 | $4.74 | $5.41 | +14% |
| 2022 | $5.41 | $3.79 | -30% |
| 2023 | $3.79 | $3.24 | -15% |
| 2024 | $3.24 | $5.25 | +62% |
| 2025 | $5.25 | $4.36 | -17% |
| 2026 YTD | $4.36 | $3.32 | -24% |
LSAK has finished lower in three of the last six years. It's down 24% so far in 2026.
MU Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $54.0 | $70.6 | +31% |
| 2021 | $70.6 | $94.4 | +34% |
| 2022 | $94.4 | $50.2 | -47% |
| 2023 | $50.2 | $85.3 | +70% |
| 2024 | $85.3 | $88.6 | +3.9% |
| 2025 | $88.6 | $284.8 | +221% |
| 2026 YTD | $284.8 | $798.4 | +180% |
MU has the edge over LSAK on returns for 2026, with the stronger performance.